Severe congenital T-lymphocytopenia may affect the outcome of neonatal intensive care
- PMID: 37431618
- DOI: 10.5507/bp.2023.028
Severe congenital T-lymphocytopenia may affect the outcome of neonatal intensive care
Abstract
Aim: Circular DNA segments TREC (T-cell receptor excision circles) formed during T-lymphocyte maturation in the thymus, are a sensitive marker of thymic lymphocyte production in a broader manner. Quantification using qPCR is proposed as a surrogate marker of T cell malfunction in various primary and secondary conditions in a non-SCID selected risk newborn population.
Methods: We collected 207 dry blood spot samples during the years 2015-2018, from newly admitted risk newborns. TREC values calculated per 106 cells were determined and a cut-off values of 5th percentile was set. The positive control group consisted of patients (n=13) with genetically confirmed SCID.
Results: The median TREC value was 34,591.56 (18,074.08-60,228.58) for girls resp. 28,391.20 (13,835.01-51,835.93) per 106 cells for boys, P=0.046. Neonates born by C-section have been found to have higher TREC levels compared to neonates born by spontaneous delivery (P=0.018). In the group of preterm newborns (n=104), 3.8% had TREC value < 5th percentile, half of them died due to sepsis as opposed to no fatalities in preterm newborns with sepsis and TREC value > 5th percentile. In the group of term newborns (n=103) 9 children (8.7%) had TREC < 5th percentile, half of them were treated for asphyxia, with no fatal complications.
Conclusion: TREC levels calculated for the 5th percentile of a risk neonatal group is suggested as a surrogate marker for increased risk of fatal septic complication. Early recognition of these newborns within a risk scoring system using TREC levels could lead to potentially lifesaving interventions.
Keywords: SCID; TREC; immunodeficiency; newborn screening; risk neonates.
Conflict of interest statement
The authors report no conflicts of interest in this work.
Similar articles
-
Neonatal Levels of T-cell Receptor Excision Circles (TREC) in Patients with 22q11.2 Deletion Syndrome and Later Disease Features.J Clin Immunol. 2015 May;35(4):408-15. doi: 10.1007/s10875-015-0153-5. Epub 2015 Mar 27. J Clin Immunol. 2015. PMID: 25814142
-
The case for severe combined immunodeficiency (SCID) and T cell lymphopenia newborn screening: saving lives…one at a time.Immunol Res. 2020 Feb;68(1):48-53. doi: 10.1007/s12026-020-09117-9. Immunol Res. 2020. PMID: 32128663
-
Cellular calibrators to quantitate T-cell receptor excision circles (TRECs) in clinical samples.Mol Genet Metab. 2012 Nov;107(3):586-91. doi: 10.1016/j.ymgme.2012.09.018. Epub 2012 Sep 21. Mol Genet Metab. 2012. PMID: 23062576 Free PMC article.
-
Newborn screening for SCID and severe T lymphocytopenia in Europe.J Allergy Clin Immunol. 2025 Feb;155(2):377-386. doi: 10.1016/j.jaci.2024.10.018. Epub 2024 Nov 6. J Allergy Clin Immunol. 2025. PMID: 39510364 Review.
-
When Screening for Severe Combined Immunodeficiency (SCID) with T Cell Receptor Excision Circles Is Not SCID: a Case-Based Review.J Clin Immunol. 2021 Feb;41(2):294-302. doi: 10.1007/s10875-020-00931-2. Epub 2021 Jan 7. J Clin Immunol. 2021. PMID: 33411155 Free PMC article. Review.
References
-
- Rudd BD. Neonatal T cells: A reinterpretation. Annu Rev Immunol 2020;38:229-47. - DOI
-
- Chan K, Puck JM. Development of population-based newborn screening of severe combined immunodeficiency. J Allergy Clin Immunol 2005;115:391-8. - DOI
-
- Kwan A, Puck JM. History and current status of newborn screening for severe combined immunodeficiency. Semin Perinatol 2015;39:194-205. - DOI
-
- Douek DC, McFarland RD, Keiser PH, Gage EA, Massey JM, Haynes BF, Polis MA, Haase AT, Feinberg MB, Sullivan JL, Jamieson BD, Zack JA, Picker LJ, Koup RA. Changes in thymic function with age and during the treatment of HIV infection. Nature 1998;396(6712):690-5. - DOI
-
- Borte S, von Döbeln U, Fasth A, Wang N, Janzi M, Winiarski J, Sack U, Pan-Hammarström Q, Borte M, Hammarström L. Neonatal screening of severe primary immunodeficiency diseases using high-throughput triplex real-time PCR. Blood 2012;15(119):2552-5. - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources